Intelligence · Clinical Development
Pipeline search results
Programs matching “alzheimer” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 141 pipeline programs matching "alzheimer" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
ML-007C-MA
MapLight Therapeutics
Psychosis Associated With Alzheimer's Disease
2 trials -
MLC901
Hospital Authority, Hong Kong
Alzheimer Disease
1 trial -
Mifepristone
CORCEPT THERAPEUTICS INC
Alzheimer's Disease
1 trial -
ORY-2001 Low dose
BRIGHT MINDS BIOSCIENCES INC.
Mild to Moderate Alzheimer's Disease
1 trial -
Pepinemab
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
Perindopril
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer's Disease
1 trial -
Pimavanserin
Acadia Pharmaceuticals B.V.
Agitation and Aggression in Alzheimer's Disease
1 trial -
Pimavanserin 34 mg
Acadia Pharmaceuticals B.V.
Agitation and Aggression in Alzheimer's Disease
1 trial -
Pimavanserin tartrate
Acadia Pharmaceuticals B.V.
Alzheimer's Disease Psychosis
1 trial -
Placebo for ML-007C-MA bilayer tablet
MapLight Therapeutics
Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis
1 trial -
Placebo to match ACP-204
Lacuna Pharma Pty Ltd
Alzheimer Disease psychosis
1 trial -
PrimeC
NeuroSense Therapeutics
Alzheimer Disease
1 trial -
Proleukin
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
SAGE-718
SUPERNUS PHARMACEUTICALS, INC.
Alzheimer Disease
1 trial -
SK-PC-B70M
Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
Alzheimer's Disease
1 trial -
SNUBH-NM-333(18F)
Hospital Authority, Hong Kong
Alzheimer Disease
1 trial -
UB-311
United Therapeutics Europe Ltd
Alzheimer's Disease
3 trials -
VY7523
Voyager Therapeutics
Alzheimer's Disease (AD)
1 trial -
Wei Li Bai capsules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Alzheimer Disease
1 trial -
[18F]PI-2620
The George Institute
Down Syndrome., Alzheimer´s Disease.
1 trial -
[18F]PI-2620
The George Institute
Down Syndrome, Alzheimer disease
1 trial -
pioglitazone
Takeda
Alzheimer Disease
1 trial -
sabirnetug
Acumen Pharmaceuticals
Alzheimer Disease
1 trial -
300 mg [C14] CT1812
COGNITION THERAPEUTICS INC
Alzheimer Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.